Atlas Trials

Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)

Clinical trial NCT06437977 · RECRUITING

Trial details

NCT number
NCT06437977
Sponsor
Shanghai Chest Hospital
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Stage II-III Non-small Cell Lung Cancer
Start date
2024-09-12
Primary completion
2027-06-01
Enrollment
478

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.